Karyopharm Therapeutics Inc. Purchase Agreements
3 Contracts & Agreements
- Securities Purchase Agreement, dated December 5, 2022, by and among the Company and the other parties thereto (Filed With SEC on December 5, 2022)
- Amendment to Asset Purchase Agreement, dated as of July 17, 2019, by and between the Registrant and Biogen MA Inc (Filed With SEC on November 3, 2021)
- Asset Purchase Agreement, dated January 24, 2018, by and between Biogen MA Inc. and the Registrant (Filed With SEC on May 10, 2018)
